Corpus Intelligence IC Memo — ST. CLAIRE MEDICAL CENTER 2026-04-26 04:03 UTC
IC Memo — ST. CLAIRE MEDICAL CENTER
Investment Committee Memorandum | KY | 100 beds | Grade C | EBITDA uplift $15.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ST. CLAIRE MEDICAL CENTER

CCN 180018 | ROWAN, KY | 100 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ST. CLAIRE MEDICAL CENTER is a 100-bed suburban community hospital in ROWAN, KY with $204.5M in net patient revenue and a -8.5% operating margin. The hospital serves a payer mix of 23.6% Medicare, 3.4% Medicaid, and 73.0% commercial.

Thesis: Turnaround. Our ML models identify $15.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -8.5% to -1.2% (+736bps).

Net Revenue HCRIS$204.5M
Current EBITDA COMPUTED$-17.5M
Operating Margin COMPUTED-8.5%
Occupancy HCRIS50.7%
Revenue / Bed COMPUTED$2.0M
Net-to-Gross HCRIS33.5%
Distress Probability ML46.8%

2. Market Context & Competitive Position

114
KY Hospitals
-0.6%
State Median Margin
44
Comparable Hospitals

KY has 114 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of -8.5% places it below the state median. Among 44 size-comparable peers (50-200 beds), the median margin is 1.0%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (50-200), prioritizing same-state peers. 44 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ST. CLAIRE MEDICAL CENTER (Target)KY100$204.5M-8.5%
BAPTIST HEALTH PADUCAHKY190$391.7M-0.5%
MERCY HEALTH LOURDES HOSPITAL KY178$288.1M7.7%
BAPTIST HEALTH CORBINKY197$285.4M1.4%
LAKE CUMBERLAND REGIONAL HOSPKY179$278.7M5.6%
BAPTIST HEALTH MADISONVILLEKY154$220.0M-5.7%
ST. ELIZABETH FLORENCEKY134$212.6M8.8%
SAINT JOSEPH EASTKY138$209.5M2.6%
EPHRAIM MCDOWELL REG MED CTRKY157$207.7M-13.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $15.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$4.3M+210bp18mo
Cost to Collect4.5%2.5%$4.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$4.0M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.5M+122bp9mo
Clean Claim Rate88.0%96.0%$131K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$4.3M
Cost to Collect
$4.1M
Denial Rate Reduction
$4.0M
A/R Days Reduction
$2.5M
Clean Claim Rate
$131K
Total EBITDA Uplift$15.1M
Current EBITDA$-17.5M
+ RCM Uplift+$15.1M
Pro Forma EBITDA$-2.4M
Current Margin-8.5%
Pro Forma Margin-1.2%
WC Released (1x)$7.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-26.9M$35.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-26.9M$30.1M0.00x-100.0%
Bull Case9.0x11.0x$-24.2M$71.1M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-24.2M$70.4M0.00x-100.0%
Bear Case11.0x10.0x$-29.6M$-31.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-29.6M$-43.9M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 44 hospitals with 50-200 beds
  • Same-state prioritization (n=45)
  • Comp margins: P25=-9.8% / P50=1.0% / P75=11.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.